Text Size

Web-Based Support for People With Schizophrenia and Their Families

This study has been completed.
Sponsor:
Information provided by:
National Institute of Mental Health (NIMH)
ClinicalTrials.gov Identifier:
NCT00177983
First received: September 13, 2005
Last updated: February 19, 2008
Last verified: February 2008
History of Changes
  Purpose

This study will assess the feasibility of using the internet and in-home computers to provide advice from health care professionals, social support, and health information to people with schizophrenia and their families.


Condition Intervention
Relapse Rates Related to Website Usage
 Behavioral: (relapse rate)

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Double-Blind
Official Title: Support to Patients and Families

Resource links provided by NLM:

MedlinePlus related topics: Schizophrenia
U.S. FDA Resources

Further study details as provided by National Institute of Mental Health (NIMH):

Primary Outcome Measures:
  • The outcome, patient relapse, will be assessed for the patients in the intervention group and control group by estimating the size of the intervention's effect on relapse rate.

Secondary Outcome Measures:
  • For the primary caregiver, the distribution of the psychological distress measure will be examined and transformation will be made if necessary for further analysis.

Estimated Enrollment: 80
Study Start Date: January 2003
Estimated Study Completion Date: January 2005
Detailed Description:

The objective of this study is to assess the feasibility of using the World Wide Web (Web) and in-home computers to provide patients suffering from schizophrenia and their families advice from health care professionals, social support, and information.

The purposes of this intervention are to improve: 1) the availability, convenience and use of needed mental health services; 2) family support for their ill family members; and 3) patient and family outcomes.

  Eligibility

Ages Eligible for Study:   14 Years to 55 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Diagnosis of schizophrenia Able to speak and read English Regular contact with a family member

Exclusion Criteria:

  • Enrolled in another study
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00177983

Locations
United States, Pennsylvania
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15261
Sponsors and Collaborators
National Institute of Mental Health (NIMH)
Investigators
Principal Investigator: Armando J Rotondi, PhD University of Pittsburgh
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00177983     History of Changes
Other Study ID Numbers: 020774
Study First Received: September 13, 2005
Last Updated: February 19, 2008
Health Authority: United States: Federal Government

Keywords provided by National Institute of Mental Health (NIMH):
Schizophrenia
Relapse
Psychological distress

Additional relevant MeSH terms:
Schizophrenia
Schizophrenia and Disorders with Psychotic Features
Mental Disorders

ClinicalTrials.gov processed this record on May 22, 2013